Guidelines for reporting health research : a user's manual /

Guidelines for Reporting Health Research is a practical guide to choosing and correctly applying the appropriate guidelines when reporting health research to ensure clear, transparent, and useful reports. This new title begins with an introduction to reporting guidelines and an overview of the impor...

Full description

Bibliographic Details
Other Authors: Moher, David, 1957- (Editor), Altman, Douglas G. (Editor), Schulz, Kenneth F. (Editor), Simera, Iveta (Editor), Wager, Elizabeth (Editor)
Format: eBook
Language:English
Published: Chichester, West Sussex : BMJ Books, Wiley Blackwell ; 2014.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Cover
  • Title Page
  • Copyright
  • Contents
  • List of Contributors
  • Foreword
  • Preface
  • Part I General Issues
  • Chapter 1 Importance of Transparent Reporting of Health Research
  • Introduction
  • What do we mean by inadequate reporting of research?
  • Consequences of nonpublication and inadequate reporting
  • Principles of reporting research
  • What can be done to improve the quality of reporting of research?
  • References
  • Chapter 2 How to Develop a Reporting Guideline
  • Deficiencies in reporting health research studies
  • The role of reporting guidelines in promoting clear and transparent reporting
  • How to develop a guideline for reporting health research articles
  • Closing comments
  • References
  • Chapter 3 Characteristics of Available Reporting Guidelines
  • Methods
  • Results
  • Descriptive information
  • Background of reporting guidelines
  • Consensus process
  • Guideline development process
  • Postconsensus activities
  • How reporting guidelines were developed
  • Comment
  • References
  • Chapter 4 Using Reporting Guidelines Effectively to Ensure Good Reporting of Health Research
  • Reporting guidelines
  • Who benefits from the use of reporting guidelines?
  • Using reporting guidelines
  • Whose responsibility is good reporting of research?
  • References
  • Chapter 5 Ambiguities and Confusions Between Reporting and Conduct
  • Examples of item-specific scenarios
  • Allocation concealment from the CONSORT 2010 statement
  • Sequence generation from the CONSORT 2010 statement
  • Discussion
  • References
  • Chapter 6 The EQUATOR Network: Helping to Achieve High Standards in the Reporting of Health Research Studies
  • EQUATOR Network
  • EQUATOR resources
  • EQUATOR future
  • Funding
  • References
  • Part II Specific Reporting Guidelines
  • Chapter 7 SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials).
  • Name of guideline
  • When to use this guideline (what types of studies it covers)
  • Current version
  • Extensions or implementations
  • Related activities
  • How best to use the guideline
  • Development process
  • Evidence of effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations (including scope)
  • Creators' preferred bits
  • Future plans
  • References
  • Chapter 8 CONSORT for Abstracts
  • Name of guideline
  • History
  • When to use this guideline (what types of studies it covers)
  • Development process
  • Current version compared with the previous versions
  • Extensions and/or implementations
  • How best to use the guideline
  • Evidence of effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations (including scope)
  • Mistakes and/or misconceptions
  • Creators' preferred bits
  • State how participants were allocated to interventions
  • For the primary outcome, a result for each group and the estimated effect size and its precision should be stated
  • Include the registration number and name of trial register
  • Future plans
  • Acknowledgments
  • References
  • Chapter 9 CONSORT
  • Name of guideline
  • When to use CONSORT
  • Current version compared with previous versions
  • Extensions and implementations of CONSORT
  • How best to use the guideline
  • Development process
  • Evidence of effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations
  • Creators' preferred bits
  • Future plans
  • References
  • Chapter 10 CONSORT Extension for Better Reporting of Harms
  • Name of guideline
  • History/development
  • When to use this guideline (what types of studies it covers)
  • Previous version
  • Current version
  • Extensions and/or implementations
  • Related activities
  • How best to use the guideline
  • Development process
  • Evidence of effectiveness of guideline.
  • Endorsement and adherence
  • Cautions and limitations (including scope)
  • Creators' preferred bits
  • Future plans
  • References
  • Chapter 11 CONSORT for Nonpharmacologic Treatments
  • Name of guideline
  • When to use the extension of the CONSORT Statement for nonpharmacologic treatments
  • Development process
  • Extension compared with the CONSORT checklist
  • How best to use the extension guidelines
  • Evidence of effectiveness of the extension guidelines
  • Endorsement and adherence
  • Cautions and limitations
  • Creators' preferred items
  • Future plans
  • References
  • Chapter 12 CONSORT for Pragmatic Trials
  • Practihc (Pragmatic Randomized Controlled Trials in Health Care)
  • History/development
  • When to use this guideline (what types of studies it covers)
  • Previous version
  • Current version
  • Extensions and/or implementations
  • Related activities
  • How best to use the guideline
  • Development process
  • Evidence of effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations (including scope)
  • Creators' preferred bits
  • Future plans
  • References
  • Chapter 13 CONSORT for Cluster Randomized Trials
  • Name of guideline
  • History/development
  • When to use this guideline (what types of studies it covers)
  • Current version/previous versions
  • Extensions and/or implementations
  • Related activities
  • How best to use the guideline
  • Evidence of effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations (including scope)
  • Mistakes and misconceptions
  • Creators' preferred bits
  • Future plans
  • References
  • Chapter 14 CONSORT for Noninferiority and Equivalence Trials
  • Name of guideline
  • History/development
  • When to use this guideline (what types of studies it covers)
  • Current version/previous versions
  • Extensions and/or implementations
  • Related activities.
  • How best to use the guideline
  • Development process
  • Evidence of effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations (including scope)
  • Mistakes and misconceptions
  • Creators' preferred bits
  • Future plans
  • References
  • Chapter 15 STRICTA (STandards for Reporting Interventions in Clinical Trials of Acupuncture)
  • Name of guideline: STRICTA
  • When to use STRICTA?
  • Development process
  • Current version
  • Evidence of effectiveness of guideline
  • Endorsement
  • Misconceptions
  • Creator's preferred bits
  • Future plans
  • References
  • Chapter 16 TREND (Transparent Reporting of Evaluations with Nonrandomized Designs)
  • Name of guideline
  • History/development
  • When to use this guideline (what types of studies it covers)
  • Current versions
  • Previous versions
  • Extensions to be aware of
  • Related activities
  • How best to use the guideline
  • Development process
  • Evidence of effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations (including scope) Mistakes and/or misconceptions
  • Creators' preferred bits
  • Future plans
  • References
  • Chapter 17 STROBE (STrengthening the Reporting of Observational studies in Epidemiology)
  • STROBE Statement
  • History/development
  • When to use this guideline (what types of studies it covers)
  • Current versions
  • Previous versions
  • Extensions to be aware of
  • Translations
  • Related activities
  • How best to use the guideline
  • Development process
  • Evidence of effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations (including scope)
  • Creators' preferred bits
  • Future plans
  • References
  • Chapter 18 STREGA (Strengthening the Reporting of Genetic Associations)
  • Strengthening the Reporting of Genetic Associations
  • When to use STREGA
  • Current version
  • Extensions
  • Related activities.
  • How best to use the guideline Authors
  • Development process
  • Evidence of effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations
  • Creators' preferred bits
  • Future plans
  • References
  • Chapter 19 STARD (STAndards for Reporting of Diagnostic Accuracy Studies)
  • History/development
  • When to use this guideline (what types of studies it covers)
  • Current versions
  • Previous versions
  • Extensions be aware of
  • Related activities
  • How best to use the guideline
  • Evidence of effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations (including scope) Mistakes and/or misconceptions
  • Creators' preferred bits
  • Future plans
  • References
  • Chapter 20 SURGE (The SUrvey Reporting GuidelinE)
  • Name of proposed guideline
  • History/overview
  • When to use this guideline (what types of studies it will cover)
  • Development process
  • Future plans/next steps
  • Evidence of effectiveness of guideline
  • References
  • Chapter 21 COREQ (Consolidated Criteria for Reporting Qualitative Studies)
  • Name of guideline
  • History/development
  • When to use this guideline (what types of studies it covers)
  • Current version
  • Extensions and/or implementations
  • Related activities
  • How best to use the guideline
  • Development process
  • Evidence of the effectiveness of guideline
  • Endorsement and adherence
  • Cautions and limitations (including scope)
  • Key features
  • Future plans
  • References
  • Chapter 22 SQUIRE (Standards for Quality Improvement Reporting Excellence)
  • Name of guideline
  • History/development
  • When to use this guideline (what types of studies it covers)
  • Previous versions
  • Current version
  • Extensions and/or implementations
  • Related activities
  • How best to use the guideline
  • Development process
  • Evidence of effectiveness of guideline.